Literature DB >> 20427123

HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.

Natlada Kanjanasut1, Kammant Phanthumchinda, Roongroj Bhidayasiri.   

Abstract

Opsoclonus-myoclonus-ataxia (OMA) syndrome is a rare neurological disorder, characterized by a rapid onset of generalized myoclonus in association with chaotic multi-directional eye movements and, less frequently, cerebellar ataxia. OMA is commonly related to a paraneoplastic process, specifically neuroblastoma in children and lung or breast cancer in adults. Nevertheless, OMA may occur in association with various infectious agents, such as Coxsackie virus B3, Epstein-Barr virus, mumps, enterovirus, and streptococcus. We recently encountered two cases of HIV-related OMA syndrome. The first patient developed a sudden onset of OMA at the time of HIV seroconversion. The second patient experienced severe ataxia with a mild degree of myoclonus and opsoclonus, associated with an elevated CD4 count following the initiation of highly active antiretroviral therapy (HAART). We suggest that OMA syndrome may be another rare manifestation of HIV infection at the time of seroconversion or during an immune restoration period.

Entities:  

Mesh:

Year:  2010        PMID: 20427123     DOI: 10.1016/j.clineuro.2010.03.024

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

Review 1.  Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.

Authors:  Hanul Srinivas Bhandari
Journal:  BMJ Case Rep       Date:  2012-08-08

2.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 3.  HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review.

Authors:  Bruno F Guedes; Márcio A A Vieira Filho; Clarice Listik; Rafael B Carra; Cristiane B Pereira; Emanuelle R da Silva; Hélio R Gomes; José E Vidal
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

4.  West nile virus encephalitis induced opsoclonus-myoclonus syndrome.

Authors:  Chad J Cooper; Sarmad Said
Journal:  Neurol Int       Date:  2014-04-22

5.  Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient.

Authors:  Thiago Cardoso Vale; Rodrigo Alencar E Silva; Mauro César Quintão E Silva Cunningham; Débora Palma Maia; Sarah Teixeira Camargos; Francisco Cardoso
Journal:  Einstein (Sao Paulo)       Date:  2013-12

6.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

7.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

Review 8.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

9.  Opsoclonus-myoclonus-ataxia syndrome in an HIV-infected child.

Authors:  Noella Maria Delia Pereira; Ira Shah; Shilpa Kulkarni
Journal:  Oxf Med Case Reports       Date:  2016-10-01

10.  Serum IgG-induced microglial activation enhances neuronal cytolysis via the NO/sGC/PKG pathway in children with opsoclonus-myoclonus syndrome and neuroblastoma.

Authors:  Xu Ding; Wei Yang; Qinghua Ren; Jiajian Hu; Shen Yang; Wei Han; Jing Wang; Xu Wang; Huanmin Wang
Journal:  J Neuroinflammation       Date:  2020-06-16       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.